Atlas Trials

Safety, Tolerability, and Pharmacokinetics of Escalating Single Doses of TAK-935

Clinical trial NCT02201056 · COMPLETED

Trial details

NCT number
NCT02201056
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2014-07-01
Primary completion
2015-07-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.